Institutional Reshuffling: Key Shifts Across Under-the-Radar Sectors

I'm told that as the market heads deeper into the second half of 2026, institutional money is quietly reshuffling positions among secondary and specialized names. According to people familiar with the matter, several infrastructure, biotech, and fintech players are undergoing significant management overhauls or business model shifts. This is perhaps the most significant reshaping of these diverse sectors we've seen this year.

Aramark (ARMK.US)

Aramark has recently been outperforming broader market segments. I'm told the company is aggressively accelerating its footprint in higher education, locking in new partnerships with five U.S. universities in early September. Revenue for the third quarter of fiscal 2026 hit USD 5.1 billion, up 9% year-over-year. According to insiders, management is highly confident in hitting their raised full-year organic revenue growth target.

Affirm (AFRM.US)

Affirm has seen a solid upward trend this year. I'm told that while inflation is pressuring consumers, it's ironically fueling demand for the company's buy-now-pay-later services. Fourth-quarter revenue jumped 33% to USD 1.17 billion. Furthermore, the Affirm Card is quietly becoming a major growth engine, with recent quarterly revenues in that segment surging 146% year-over-year.

Waste Management (WM.US)

WM has maintained a steady trajectory in recent months. Here is a major shakeup for the environmental services sector: CEO Jim Fish is retiring, handing the reins to John Morris. I'm told this transition has been in the works for a while. Concurrently, the company is accelerating automated equipment tests at its "Landfill of the Future" in Arizona, aiming to roll out broader operational efficiencies later this year.

Intellia Therapeutics (NTLA.US)

Shares of Intellia have rallied roughly 38% year-to-date. According to people familiar with the matter, the company just secured a massive USD 400 million debt financing deal with OrbiMed, entirely betting on the commercialization of its lonvo-z drug for hereditary angioedema. It is a bold financial maneuver that ties the company's near-term funding closely to the success of a single candidate.

VNET Group (VNET.US)

Despite some recent pressure on its stock price, VNET is undergoing a fundamental business pivot. I'm told that for the first time, its wholesale data center revenue surpassed the retail side in the second quarter of 2026, bolstered by a massive 345-megawatt order from a leading cloud provider. Insiders suggest that crossing the 1-gigawatt mark in utilized capacity is just the beginning of a broader land-grab strategy.

Unity Software (U.US)

Unity's stock has faced a pullback since late August over investor concerns regarding its ad-tech growth deceleration. And yet, the company still posted a 24% revenue bump to USD 546 million in the second quarter. I'm told that management is ruthlessly winding down non-strategic operations, aiming to complete its transformation into a high-margin AI advertising platform before the next earnings call.

Also

• Franklin FTSE South Korea ETF (FLKR.US): The traditional valuation discount is reportedly vanishing, and geopolitical risks could prompt some portfolio rebalancing.
• Orion Energy Systems (OESX.US): Fresh off a 32% revenue spike in its fiscal first quarter, I understand executives plan to unveil more details about their data center lighting expansion at an investment conference later this month.
• Invesco DB Commodity Index Tracking Fund (PDBC.US): The ETF is quietly managing roll yields as backwardation and contango dynamics shift across energy and metals markets.
• Advanced Battery Technologies (ABAT.US): With solid-state and lithium-sulfur chemistries showing promise, defense sectors are reportedly beginning to scope out next-generation power suppliers.

This article does not constitute investment advice.